Naturally occurring anticoagulants and bone marrow transplantation: Plasma protein C predicts the development of venocclusive disease of the liver

Elena M. Faioni, Alessandro Krachmalnicoff, Scott I. Bearman, Augusto B. Federici, Adriano Decarli, Alessandro M. Gianni, George B. McDonald, Pier Mannuccio Mannucci

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Venocclusive disease (VOD) of the liver is the major dose-limiting complication of pretransplant regimens for bone marrow transplantation. Recent reports from different groups point to the involvement of the hemostatic mechanism in the development of VOD. We measured the naturally occurring anticoagulants protein C, antithrombin III, and protein S in 45 patients undergoing bone marrow transplantation for hematologic malignancies before cytoreductive therapy and after transplant. The aim of this prospective study was both to evaluate the status of the naturally occurring anticoagulant pathway in patients who develop VOD compared with patients who do not, and to find a predictive marker of VOD. In transplant patients, protein C decreased from before cytoreductive therapy to posttransplant, whereas protein S and antithrombin III did not. In a multivariate analysis, protein C was the only variable that could independently discriminate between VOD and non-VOD patients at all times. Discriminant function analysis established that low protein C levels before cytoreductive therapy predicted the occurrence of VOD with good sensitivity and specificity.

Original languageEnglish
Pages (from-to)3458-3462
Number of pages5
JournalBlood
Volume81
Issue number12
Publication statusPublished - Jun 15 1993

Fingerprint

Protein C
Bone Marrow Transplantation
Liver
Anticoagulants
Liver Diseases
Blood Proteins
Bone
Antithrombin III
Protein S
Transplants
Antithrombin Proteins
Point groups
Discriminant Analysis
Hemostatics
Hematologic Neoplasms
Therapeutics
Multivariate Analysis
Prospective Studies
Sensitivity and Specificity

ASJC Scopus subject areas

  • Hematology

Cite this

Faioni, E. M., Krachmalnicoff, A., Bearman, S. I., Federici, A. B., Decarli, A., Gianni, A. M., ... Mannucci, P. M. (1993). Naturally occurring anticoagulants and bone marrow transplantation: Plasma protein C predicts the development of venocclusive disease of the liver. Blood, 81(12), 3458-3462.

Naturally occurring anticoagulants and bone marrow transplantation : Plasma protein C predicts the development of venocclusive disease of the liver. / Faioni, Elena M.; Krachmalnicoff, Alessandro; Bearman, Scott I.; Federici, Augusto B.; Decarli, Adriano; Gianni, Alessandro M.; McDonald, George B.; Mannucci, Pier Mannuccio.

In: Blood, Vol. 81, No. 12, 15.06.1993, p. 3458-3462.

Research output: Contribution to journalArticle

Faioni, EM, Krachmalnicoff, A, Bearman, SI, Federici, AB, Decarli, A, Gianni, AM, McDonald, GB & Mannucci, PM 1993, 'Naturally occurring anticoagulants and bone marrow transplantation: Plasma protein C predicts the development of venocclusive disease of the liver', Blood, vol. 81, no. 12, pp. 3458-3462.
Faioni EM, Krachmalnicoff A, Bearman SI, Federici AB, Decarli A, Gianni AM et al. Naturally occurring anticoagulants and bone marrow transplantation: Plasma protein C predicts the development of venocclusive disease of the liver. Blood. 1993 Jun 15;81(12):3458-3462.
Faioni, Elena M. ; Krachmalnicoff, Alessandro ; Bearman, Scott I. ; Federici, Augusto B. ; Decarli, Adriano ; Gianni, Alessandro M. ; McDonald, George B. ; Mannucci, Pier Mannuccio. / Naturally occurring anticoagulants and bone marrow transplantation : Plasma protein C predicts the development of venocclusive disease of the liver. In: Blood. 1993 ; Vol. 81, No. 12. pp. 3458-3462.
@article{35c02d73656e4741ba0b70cf5c88d77b,
title = "Naturally occurring anticoagulants and bone marrow transplantation: Plasma protein C predicts the development of venocclusive disease of the liver",
abstract = "Venocclusive disease (VOD) of the liver is the major dose-limiting complication of pretransplant regimens for bone marrow transplantation. Recent reports from different groups point to the involvement of the hemostatic mechanism in the development of VOD. We measured the naturally occurring anticoagulants protein C, antithrombin III, and protein S in 45 patients undergoing bone marrow transplantation for hematologic malignancies before cytoreductive therapy and after transplant. The aim of this prospective study was both to evaluate the status of the naturally occurring anticoagulant pathway in patients who develop VOD compared with patients who do not, and to find a predictive marker of VOD. In transplant patients, protein C decreased from before cytoreductive therapy to posttransplant, whereas protein S and antithrombin III did not. In a multivariate analysis, protein C was the only variable that could independently discriminate between VOD and non-VOD patients at all times. Discriminant function analysis established that low protein C levels before cytoreductive therapy predicted the occurrence of VOD with good sensitivity and specificity.",
author = "Faioni, {Elena M.} and Alessandro Krachmalnicoff and Bearman, {Scott I.} and Federici, {Augusto B.} and Adriano Decarli and Gianni, {Alessandro M.} and McDonald, {George B.} and Mannucci, {Pier Mannuccio}",
year = "1993",
month = "6",
day = "15",
language = "English",
volume = "81",
pages = "3458--3462",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Naturally occurring anticoagulants and bone marrow transplantation

T2 - Plasma protein C predicts the development of venocclusive disease of the liver

AU - Faioni, Elena M.

AU - Krachmalnicoff, Alessandro

AU - Bearman, Scott I.

AU - Federici, Augusto B.

AU - Decarli, Adriano

AU - Gianni, Alessandro M.

AU - McDonald, George B.

AU - Mannucci, Pier Mannuccio

PY - 1993/6/15

Y1 - 1993/6/15

N2 - Venocclusive disease (VOD) of the liver is the major dose-limiting complication of pretransplant regimens for bone marrow transplantation. Recent reports from different groups point to the involvement of the hemostatic mechanism in the development of VOD. We measured the naturally occurring anticoagulants protein C, antithrombin III, and protein S in 45 patients undergoing bone marrow transplantation for hematologic malignancies before cytoreductive therapy and after transplant. The aim of this prospective study was both to evaluate the status of the naturally occurring anticoagulant pathway in patients who develop VOD compared with patients who do not, and to find a predictive marker of VOD. In transplant patients, protein C decreased from before cytoreductive therapy to posttransplant, whereas protein S and antithrombin III did not. In a multivariate analysis, protein C was the only variable that could independently discriminate between VOD and non-VOD patients at all times. Discriminant function analysis established that low protein C levels before cytoreductive therapy predicted the occurrence of VOD with good sensitivity and specificity.

AB - Venocclusive disease (VOD) of the liver is the major dose-limiting complication of pretransplant regimens for bone marrow transplantation. Recent reports from different groups point to the involvement of the hemostatic mechanism in the development of VOD. We measured the naturally occurring anticoagulants protein C, antithrombin III, and protein S in 45 patients undergoing bone marrow transplantation for hematologic malignancies before cytoreductive therapy and after transplant. The aim of this prospective study was both to evaluate the status of the naturally occurring anticoagulant pathway in patients who develop VOD compared with patients who do not, and to find a predictive marker of VOD. In transplant patients, protein C decreased from before cytoreductive therapy to posttransplant, whereas protein S and antithrombin III did not. In a multivariate analysis, protein C was the only variable that could independently discriminate between VOD and non-VOD patients at all times. Discriminant function analysis established that low protein C levels before cytoreductive therapy predicted the occurrence of VOD with good sensitivity and specificity.

UR - http://www.scopus.com/inward/record.url?scp=0027225620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027225620&partnerID=8YFLogxK

M3 - Article

C2 - 8507881

AN - SCOPUS:0027225620

VL - 81

SP - 3458

EP - 3462

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -